| 000 | 01508 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250516060525.0 | ||
| 264 | 0 | _c20120120 | |
| 008 | 201201s 0 0 eng d | ||
| 022 | _a1530-8561 | ||
| 024 | 7 |
_a10.1373/clinchem.2011.172254 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchwaninger, Andrea E | |
| 245 | 0 | 0 |
_aUrinary excretion kinetics of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its phase I and phase II metabolites in humans following controlled MDMA administration. _h[electronic resource] |
| 260 |
_bClinical chemistry _cDec 2011 |
||
| 300 |
_a1748-56 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aGlucuronides _xurine |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMetabolic Detoxication, Phase I |
| 650 | 0 | 4 | _aMetabolic Detoxication, Phase II |
| 650 | 0 | 4 |
_aN-Methyl-3,4-methylenedioxyamphetamine _xadministration & dosage |
| 650 | 0 | 4 |
_aSulfuric Acid Esters _xurine |
| 700 | 1 | _aMeyer, Markus R | |
| 700 | 1 | _aBarnes, Allan J | |
| 700 | 1 | _aKolbrich-Spargo, Erin A | |
| 700 | 1 | _aGorelick, David A | |
| 700 | 1 | _aGoodwin, Robert S | |
| 700 | 1 | _aHuestis, Marilyn A | |
| 700 | 1 | _aMaurer, Hans H | |
| 773 | 0 |
_tClinical chemistry _gvol. 57 _gno. 12 _gp. 1748-56 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1373/clinchem.2011.172254 _zAvailable from publisher's website |
| 999 |
_c21214491 _d21214491 |
||